Our PGx panels provide broad coverage. No duplicate samples, no reagent waste. Single run CNV and genotyping detection.
Discover how labs across the world use our core technology to achieve faster decisions and greater productivity in precision medicine.

The VeriDose Core Panel targets the most relevant variants in 20 principle genes implicated in drug metabolism pathways. It provides genotype information for 68 SNPs/INDELs across 20 genes. The panel is designed to be tolerant to low quality DNA, boosting the likelihood of success with challenging samples.
Learn More
Dr. Vicky Pratt, past president of AMP, and Prof. Dr. Ron van Schaik, past president of ESPT, discuss the clinical evidence, recommendations and considerations supporting DPYD testing…
Watch Now29 November 2021
14 September 2021